Comparison Overview

Mira Therapeutics

VS

UCLA Depression Grand Challenge

Mira Therapeutics

undefined, Hoboken, NJ, 07030, US
Last Update: 2026-01-21
Between 750 and 799

Mira Therapeutics is a digital health company changing the way people recover and grow from trauma. Through a combination of self-management tools, symptom tracking, and a therapist platform, Mira Therapeutics empowers users to better cope with their symptoms, and enables therapists to deliver personalized, measurement-based care.  Our first product, the Mira App, helps users manage their symptoms when they occur, educates about trauma, and tracks events and triggers that inform treatment decisions.

NAICS: 621
NAICS Definition:
Employees: 1
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

UCLA Depression Grand Challenge

760 Westwood Plaza, Los Angeles, California, 90024, US
Last Update: 2025-11-11

The UCLA Depression Grand Challenge (DGC) was initiated to cut the burden of depression in half by 2050 and eliminate it by the end of the century. Depression is recognized by the World Health Organization as the leading cause of disability worldwide. Please visit https://grandchallenges.ucla.edu/depression/approach/ to learn more about the DGC's approach.

NAICS: 621
NAICS Definition:
Employees: 25
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/miratherapeutics.jpeg
Mira Therapeutics
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/ucla-dgc.jpeg
UCLA Depression Grand Challenge
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Mira Therapeutics
100%
Compliance Rate
0/4 Standards Verified
UCLA Depression Grand Challenge
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Mental Health Care Industry Average (This Year)

No incidents recorded for Mira Therapeutics in 2026.

Incidents vs Mental Health Care Industry Average (This Year)

No incidents recorded for UCLA Depression Grand Challenge in 2026.

Incident History — Mira Therapeutics (X = Date, Y = Severity)

Mira Therapeutics cyber incidents detection timeline including parent company and subsidiaries

Incident History — UCLA Depression Grand Challenge (X = Date, Y = Severity)

UCLA Depression Grand Challenge cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/miratherapeutics.jpeg
Mira Therapeutics
Incidents

No Incident

https://images.rankiteo.com/companyimages/ucla-dgc.jpeg
UCLA Depression Grand Challenge
Incidents

No Incident

FAQ

UCLA Depression Grand Challenge company demonstrates a stronger AI Cybersecurity Score compared to Mira Therapeutics company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, UCLA Depression Grand Challenge company has disclosed a higher number of cyber incidents compared to Mira Therapeutics company.

In the current year, UCLA Depression Grand Challenge company and Mira Therapeutics company have not reported any cyber incidents.

Neither UCLA Depression Grand Challenge company nor Mira Therapeutics company has reported experiencing a ransomware attack publicly.

Neither UCLA Depression Grand Challenge company nor Mira Therapeutics company has reported experiencing a data breach publicly.

Neither UCLA Depression Grand Challenge company nor Mira Therapeutics company has reported experiencing targeted cyberattacks publicly.

Neither Mira Therapeutics company nor UCLA Depression Grand Challenge company has reported experiencing or disclosing vulnerabilities publicly.

Neither Mira Therapeutics nor UCLA Depression Grand Challenge holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Mira Therapeutics company nor UCLA Depression Grand Challenge company has publicly disclosed detailed information about the number of their subsidiaries.

UCLA Depression Grand Challenge company employs more people globally than Mira Therapeutics company, reflecting its scale as a Mental Health Care.

Neither Mira Therapeutics nor UCLA Depression Grand Challenge holds SOC 2 Type 1 certification.

Neither Mira Therapeutics nor UCLA Depression Grand Challenge holds SOC 2 Type 2 certification.

Neither Mira Therapeutics nor UCLA Depression Grand Challenge holds ISO 27001 certification.

Neither Mira Therapeutics nor UCLA Depression Grand Challenge holds PCI DSS certification.

Neither Mira Therapeutics nor UCLA Depression Grand Challenge holds HIPAA certification.

Neither Mira Therapeutics nor UCLA Depression Grand Challenge holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

SummaryA command injection vulnerability (CWE-78) has been found to exist in the `wrangler pages deploy` command. The issue occurs because the `--commit-hash` parameter is passed directly to a shell command without proper validation or sanitization, allowing an attacker with control of `--commit-hash` to execute arbitrary commands on the system running Wrangler. Root causeThe commitHash variable, derived from user input via the --commit-hash CLI argument, is interpolated directly into a shell command using template literals (e.g.,  execSync(`git show -s --format=%B ${commitHash}`)). Shell metacharacters are interpreted by the shell, enabling command execution. ImpactThis vulnerability is generally hard to exploit, as it requires --commit-hash to be attacker controlled. The vulnerability primarily affects CI/CD environments where `wrangler pages deploy` is used in automated pipelines and the --commit-hash parameter is populated from external, potentially untrusted sources. An attacker could exploit this to: * Run any shell command. * Exfiltrate environment variables. * Compromise the CI runner to install backdoors or modify build artifacts. Credits Disclosed responsibly by kny4hacker. Mitigation * Wrangler v4 users are requested to upgrade to Wrangler v4.59.1 or higher. * Wrangler v3 users are requested to upgrade to Wrangler v3.114.17 or higher. * Users on Wrangler v2 (EOL) should upgrade to a supported major version.

Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.2 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H).

Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
Description

Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle VM VirtualBox accessible data as well as unauthorized access to critical data or complete access to all Oracle VM VirtualBox accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.1 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:L).

Risk Information
cvss3
Base: 8.1
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:L
Description

Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.2 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H).

Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
Description

Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.2 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H).

Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H